Skip to main content

Table 3 Independent risk factors for upstaging to invasive cancer in DCIS patients

From: Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis

Characteristic

OR

95% CI

p-value

Preoperative tumour size > 5 cm

1.049

0.347–3.172

0.933

Presence of ultrasonic mass

2.782

1.224–6.320

0.015

Multicentric tumour location

1.244

0.374–4.138

0.722

Core-needle biopsy as a diagnostic method

6.861

2.429–19.379

 < 0.001

TM

1.738

0.796–3.796

0.166

Comedo necrosis

0.972

0.406–2.327

0.950

High nuclear grade

1.263

0.321–4.970

0.738

ER-negative

0.830

0.290–2.378

0.729

PR-negative

3.156

1.197–8.323

0.020

High Ki-67 labelling index

1.167

0.519–2.623

0.710

Comedo type DCIS

0.972

0.406–2.327

0.950

  1. CI confidence interval, DCISductal carcinoma in situ, ER oestrogen receptor, OR odds ratio, PR progesterone receptor, TM total mastectomy